Jim Cramer Says He Blessed MannKind as a Speculation Only

MannKind Corporation (NASDAQ:MNKD) was among the stocks Jim Cramer highlighted on Mad Money as he noted that the market has an appetite for stocks. Answering a caller’s query about the stock during the lightning round, Cramer stated:

100% speculation, a total speculation. In my book, I talk about how you can have one speculation, and then you have to have other stocks that are, you know, considered to be a little bit more earnings-oriented. This would fit as that speculation, so I blessed it for that purpose only.

Photo by Artem Podrez on Pexels

MannKind Corporation (NASDAQ:MNKD) is a biopharmaceutical company that develops and commercializes inhaled therapies, wearable delivery devices, and injectable treatments to manage chronic conditions like diabetes, pulmonary hypertension, and fluid overload.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.